Disclosed are anthranilic amide derivatives having the formula. Compositions are disclosed that include the anthranilic amide derivatives and the use of the anthranilic amide derivatives for the manufacture of a medicament. Further disclosed are methods of inhibiting or treating cancer, inhibiting or reversing an epithelial to mesenchymal cellular transition, and/or inhibiting MEK1/2 and/or MEK 5 enzymatic activity in a subject by administering to the subject an effective amount of a disclosed anthranilic amide derivative.
本发明揭示了具有以下公式的
蒽酰胺衍
生物。本发明还揭示了包括该
蒽酰胺衍
生物的组合物以及使用该
蒽酰胺衍
生物制备药物的用途。此外,本发明还揭示了通过向受试者施用揭示的
蒽酰胺衍
生物的有效量来抑制或治疗癌症,抑制或逆转上皮-间充质细胞转化,并/或抑制MEK1/2和/或MEK 5酶活性的方法。